INTRODUCTION
Terpenoids represent a highly diverse class of natural products with a multitude of applications in 35 modern society ranging from renewable fuels to structurally complex medicinal compounds (1). For 36 example they constitute the active compounds in several medicinal plant species including 37 paclitaxel (Taxus brevifolia), forskolin (Coleus forskohlii) and artemisinin (Artemisia annua). 38 Although several terpenoid derived natural products are currently in or have passed clinical trial for 39 treatment of a number of conditions (2), sufficient supply of the molecules remains an obstacle. 40 Purification from naturally producing plants has proven infeasible in many cases due to low yield, 41 while establishment of heterologous production systems have been hampered by insufficient insight 42 into the biosynthetic routes. However, the advent and rapid development of whole genome and 43 transcriptome sequencing have paved the way for several recent breakthroughs. Particularly tissue 44 specific metabolomics combined with RNA deep sequencing is an exceptionally promising 45 approach for gene discovery in non-model organisms (3, 4) . 46 Our interest is focused on the diterpene forskolin produced by C. forskohlii. Forskolin is a 47 promising pharmaceutical which has shown potential as treatment against a wide range of diseases 48 (5-9). Forskolin is currently approved for treatment of glaucoma and heart-failure, while clinical 49 trials against several forms of cancer are ongoing -the compound has been tested in over 800 50 independent assays and in 76 cases forskolin was reported to be potently active (< 2 micro molar) 51 including activity as D3 dopamine and relaxin receptor agonist, as allosteric activator of Mas 52 related G-protein coupled receptor X1 and as antagonist of the androgen receptor (PubChem, 53 accessed August 2014 http://pubchem.ncbi.nlm.nih.gov). Finally, forskolin is extensively used in 54 basic research as an inhibitor of protein kinases (more than 50,000 publications in Web of Science, 55 Thompson Reuters). Recently, the combined use of metabolomics and RNA deep sequencing were 56 successfully applied to C. forskohlii root cells resulting in identification of two diterpene synthases, 57 4 CfTPS2 and CfTPS3, that catalyze the formation of (13R)-manoyl oxide (13R-MO) from 58 geranylgeranyl diphosphate (GGPP) (10). 13R-MO is proposed to be the first dedicated 59 intermediate in forskolin biosynthesis (11) .With this first biosynthetic knowledge in hand, 60 establishment of a microbial system for further elucidation of the biosynthetic route as well as 61 production of forskolin comes within reach.
62
From a microbial engineering perspective, terpenoids constitute an attractive class of compounds as 63 they are all derived from a single precursor, isopentenyl pyrophosphate (IPP), and its isomer 64 dimethylallyl pyrophosphate (DMAPP). Substantial efforts have therefore been made in increasing 65 IPP-supply as a driver for efficient terpenoid synthesis in microbes (12). IPP can be synthesized 66 through two biochemical routes; the mevalonate (MEV), and the 1-deoxy-D-xylulose 5-phosphate 67 (DXP) pathways, with the MEV-pathway being prevalent in eukaryotes and archea, while the DXP-68 pathway dominates in eubacteria. While both routes have been subjected to numerous engineering 69 efforts, the MEV-pathway has been most successfully applied in Escherichia coli (12, 13 conversion of IPP to the general diterpene precursor, GGPP, is very inefficient in wild type E. coli 75 strains and therefore requires introduction of a heterologous 15) . As previously 76 shown for the C15 sesquiterpene amorphadiene, a substantial increase in product yield can be 77 gained by combining a heterologous farnesyl diphosphate (FPP) synthase with the minimal 78 consensus set of MEV-pathway genes (16). Likewise, high-level supply of GGPP in E. coli requires 79 coordinated expression of a minimum of five genes: four for producing the precursor IPP/DMAPP 80 (for example S. cerevisiae ERG12, ERG8, MVD1 and E. coli idi2), and one for a GGPP synthase.
81
As this consensus set is independent of the target diterpene, assembling all five genes on a single 82 plasmid would substantially simplify experimental designs such as strain screenings. The Keasling 83 group have reported the construction and verification of a single plasmid for synthesis of farnesyl 84 diphosphate (13). Previous attempts of adaptation of this strategy for synthesis of GGPP 85 unfortunately resulted in a non-functional plasmid (16). We have recently described a set of design 86 principles for standardizing molecular cloning and formulation of a cloning pipeline to simplify 87 multi-gene expression in E. coli (17) . Here, we take advantage of this bioengineering pipeline to 
MATERIALS AND METHODS
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Bacterial strains and media. Escherichia coli strain NEB5α was used for cloning and propagation 97 of plasmids. BL21(DE3) was used for radioactive labeling studies and KRX (Promega, Madison, 98 USA) for production of 13R-MO. Following transformations, bacteria were propagated on Luria-99 Bertoni (LB) agar plates supplemented with ampicillin (100 µg/ml), spectinomycin (50 µg/ml), 100 kanamycin (50 µg/ml) or in combinations (ampicillin 50 µg/ml, spectinomycin 25 µg/ml, 101 kanamycin 25 µg/ml) when required. Liquid cultures for plasmid preparation were based on 2xYT 102 media, whereas pre-cultures for assays were prepared in LB media using antibiotic concentrations 103 as described above. The PASM-5052 defined media used for expression assays were prepared as 104 described by Studier (18) except for the exchange of Seleno methionine with methionine. For long 105 term incubations (more than 24 h) ampicillin was replaced by carbencillin (50 µg/ml) as previously (AWH04047.1) and CfTPS3 (AWH04048.1) were amplified from previously described constructs 113 (10). AgGGPP (AF425235.2) was codon optimized for E. coli and synthetically synthesized 114 (Genscript, Piscataway, USA). USER Fusion DNA assembly was performed essentially as 115 described by Geu Flores et al (21) . Purified PCR products of inserts and vector were mixed in a 116 total insert to vector ratio of 6:1 (volume). When several DNA fragments were cloned 117 simultaneously, use of equimolar amounts of each fragment was approximated by agarose gel 118 analysis. The reaction mixture was buffered with 5x Phusion HF buffer (Invitrogen) and 1 U of 119 USER TM enzyme mix (New England Biolabs, Ipswich, USA) was added. The reaction mixture was 120 incubated for 20 min at 37°C, followed by 20 min at 25°C before transformation of chemically 121 competent E. coli cells. All oligo nucleotides and synthetic genes used in this study are summarized 122 in Table S1 . Vector-backbones used in multi-fragment assemblies were likewise amplified with generic oligo 131 nucleotides. All plasmids containing ORFs were verified by sequencing. (Fig. S1 ). From these entry clones, ScMVD1, ScERG8, ScERG12, Ecidi2 and 208 AgGGPPs were subsequently assembled into the plasmid pGGPP for GGPP synthesis, while 209 CfTPS2 and CfTPS3 were assembled into pMO for conversion of GGPP into 13R-MO (Fig. 1B) . In 210 the setup employed here, the T7-promoter and a consensus Shine-Dalgarno sequence were 211 maintained as transcriptional units in front of every ORF encoding the entry fragment in the 212 assemblies ( Fig. 1B) . 1 and 2 (Fig. 2A and B) . Supplementation of 224 mevalonolactone to pGGPP containing cultures resulted in a modest, yet significant, increase in the 225 yield of both compounds (Fig. 2C) . The compounds were tentatively identified as 13R-MO and CfTPS3, (10) (see Fig. 2 ) and therefore indicated that the current process is sub-optimal. 237 Process optimization facilitates increased yieldSeveral studies have demonstrated that substantial 238 improvements of microbial production systems can be achieved using a simple set of process 239 optimization steps including alteration of culture parameters and recovery procedures (13, 16, 29) . had a significant impact on diterpene yield when compared to the initial protocol contributing a 2-248 fold yield increase each (Fig. 3) . These yield improvements proved to be cumulative when 249 combined resulting in an approximately 5-fold total increase over the initial protocol. Under these 250 experimental conditions, the process, however, still resulted in formation of both 13S-and 13R-MO 251 in approximately equal amounts. At this stage, the expression level of CfTPS3 from pMO was 252 examined in detail. Remarkably, when pMO was transformed into BL21(DE3) and subjected to 35 S-253 methionine labeling, only CfTPS2 expression was detected (Fig. S1 ). Since it was already 254 established that both CfTPS2 and CfTPS3 could be transcribed and translated in E. coli when 255 expressed alone (Fig. S1 ), these findings indicated that transcription from the second T7 promoter is 256 impeded in pMO. To test this hypothesis, we established a three-plasmid system consisting of 257 pGGPP, pCfTPS2 and pCfTPS3. Indeed, when the three plasmids were co-transformed into E. coli 258 KRX cells and cultivated in consistence with the optimal parameters identified above, biosynthesis 259 of enantiomerically pure 13R-MO was obtained (Fig. 4A) . Moreover, the flux through the pathway 260 was dramatically increased resulting in a more than two thousand fold yield increase over the initial 261 protocol.
262
Recovery, structure validation and absolute quantification. An advantage of the E. coli based 263 biosynthesis of diterpenes is high purity and therefore simple downstream processing. Indeed, with 264 the hexane-based extraction utilized in this study, merely three compounds were observed with GC-265 MS in addition to 13R-MO. Two of these (4 and 5), could be attributed to impurities arising from 266 the instrument (data not shown) and are thus experimental artifacts rather than genuine compounds 267 present in the extract. The one remaining metabolite, 3, was identified as indole by comparison of 268 retention time and mass spectra with an authentic standard (Fig. 4B) . Indole is known to be a 269 signaling molecule in E. coli with substantial influence on metabolism and membrane potential (30, 270 31) and has been reported to inhibit terpene synthesis in E. coli (29) . Thus elimination of indole 271 formation might not only simplify recovery, but also increase yield. Recently, it was discovered that (Fig. 4A) . Importantly, the overall yield of 13R-MO 277 was unaffected. Following a simple removal of impurities by solid phase extraction, the recovered 278 13R-MO was sufficiently pure for absolute identification by NMR analysis (see Table 1 ). The yield 279 of the established process was quantified absolutely to 10 mg/l, by GC-MS using a standard curve controlled bioreactors has proven essential obtaining gram scale yield (34, 35) . Our aim is to use 296 microbial systems for elucidation of biosynthetic pathways to high-value diterpenoids and 297 simultaneously establish a microbial cell factory. Since gene discovery is likely to require a 298 substantial screening effort, it was crucial for us to develop a process compatible with micro-scale 299 cultures. We describe here the assembly of a single plasmid harboring five ORFs encoding enzymes 300 sufficient for efficient GGPP synthesis from mevalonate in E. coli. Maintaining all these enzymatic 301 functions on one plasmid substantially increases the flexibility in experimental design by serving as 302 a platform to facilitate high throughput screening of novel diTPS candidates in different microbial 303 strains. For our proof-of-principle, the process was optimized from affording trace amounts of two 304 isomers, 13R-MO and 13S-MO, to obtaining 10 mg/l of enantiopure 13R-MO, corresponding to a 305 more than two thousand fold increase. As such, our findings are comparable to previous findings 306 regarding yield increase in micro-scale cultures (16, 33, 35) , which hints that further engineering 307 and culture scale up can substantially increase yield of 13R-MO, although the previously proposed 308 cytotoxic effects (37-40) may represent a challenge. However, our interest in 13R-MO is 309 exclusively as a pre-cursor for forskolin, thus maintaining the micro-scale format is crucial at this 310 16 stage. Moreover, Ajikumar and co-workers observed that the strain developed for efficient 311 production of the olefin taxadiene (1g/l) (29), merely produced 50mg/l of the next biosynthetic 312 intermediate taxadien-5α-ol, thus indicating that careful balancing of enzyme activities might be 313 most relevant once a complete pathway is assembled. We expect that the microbial synthesis 314 process described here will serve as a foundation for full elucidation of the forskolin biosynthetic 315 pathway by providing complex precursor molecules for in vitro assays and facilitate high-316 throughput in vivo screening. In due course, the microbial process may also be developed into a cell 317 factory for sustainable production of forskolin and other labdane-type terpenes. 
